Management Board Meets to Discuss EMA Premises in Amsterdam

February 7, 2018

Applied Clinical Trials

The European Medicines Agency’s Management Board met to discuss EMA’s future premises in Amsterdam. With the anticipated move in March of 2019, the EMA needs to have a designated location to operate, but with this discussion it has been seen that the building will not be completed in time and they will have to settle upon a temporary premises.

Read the full release here

Related Content:

News